1. Adverse Drug Reactions Advisory Committee. Augmentin jaundice. Australia Adverse Drug Reactions Bull. November 1990:2
2. Angelin DL, et al. Effect of penicillin on nasopharyngeal colonization with s. pneumoniae in children with sickle cell disease. Pediatirics 1984;104:18-22
3. Buchanan GR, et al. Pneumococcal septicemia despite penicillin prophylaxis in children with sickle cell disease. Am J Dis Child 1986;140:428-32
4. Bassili A, et al. Profile of secondary prophylaxis among children with rheumatic heart disease in Egypt. East Mediterr Health J 2000;6(2/3):437-446
5. Bassily SB, et al. Chronic salmonella bacteriuria with intermittent bactermia treated with low doses of amoxicillin or ampicillin. Antimicrob Agents Chemother 1981 Nov;20(5):630-3
6. Cooper J, et al. Prophylactic treatment of chronic bronchitis comparing co-trimoxazole and amoxicillin. Br J Clin Pract 1975 NOV;29(11):307-310
7. Dattwyler RJ, et al. Amoxicillin plus probenecid vs. doxycycline for treatment of erythema migrans borreliosis. Lancet 1990;336(8728):1404-1406
8. Dowsett, JF, et al. Amoxcillin.clavulanic acid induced intrahepatic cholestasis. Dig Dis Sci 1989;34:1290-1293
9. Farid Z, et al. Treatment of chronic enteric fever with amoxicillin. J Infect Dis 1975 Dec;132(6):698-701
10. Garcia Rodriguez LA, et al. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med 1996;156:1327-1332
11. Gatson MH, et al. Prophylaxis with oral penicillin in children with sickle cell disease. NEJM 1986;314(25):1593-9
12. Hebbard GS, et al. Augmentin-induced juandice with a fatal outcome. Med J Aust 1992;156:285-286
13. John, AB, et al. Prevention of pneumococcal infection in children with homozygous sickle cell disease. Brit Med J 1984 May;288(6430):1567-70.
14. Larrey D, et al. Hepatitis associated with amoxicillin-clavulanic acid combination report of 15 cases. Gut 1992;33:368-371
15. Lue HC, et al. Long-term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks vs. every four weeks. J Pediatr 1994 Nov;125(5 pt 1):812-816
16. Massell BF, et al. Prophylaxis of streptococcal infections and rheumatic fever. JAMA 1979 Apr;241(15):1589-94.
17. Medicine Control Agency. Cholestatic juandice with co-amoxclav. Curr Probl Pharmacovig 1993;19:2
18. Nolan CM, et al. Treatment of typhoid carriers with amoxicillin. Correlates of successful therapy. JAMA 1978 Jun 2;239(22):2352-4
19. Oski J, et al. Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated lyme borreliosis. Eur J Clin Microbiol Infect Dis 1998; 17:715-719.
20. Schneider JE, et al. Cholestatic hepatitis after therapy with amoxicillin/clavulanate. NY State J Med 1989;6:355-356
21. Seligman S, et al. Treatment of enterococcal endocaridits with oral amoxicillin and IM gentamicin. J Infect Dis 1974;129(suppl):S213-215
22. Silvain C, et al. Granulomatous hepatitis sue to combination of amoxicillin and clavulanate. Dig Dis Sci 1992;37:150-152
23. Stricker BH, et al. Drug induced hepatic injury. Amsterdam, the Netherlands: Elsevier Science Publishers; 1992
24. Stricker BH, et al. Cholestatic hepatitis due to amoxicillin and clavulanic acid. Dig Dis Sci 1989;34:1576-1580
25. Thomsen J, et al. Long-term antibiotic treatment of children with secretory otitis media. Acta Otolaryngol 1998;449:49-50.
26. Wood HF, et al. The comparative effectiveness of three prophylactic regimens in preventing rheumatic recurrences. Ann Int Med 1964;60(suppl):31-46
27. Van den Broek JW, et al. Cholestatic hepatitis due to amoxicillin and clavulanic acid. Ned Tijdschr Geneeskd. 1988;132:1495-1497
28. Verhamme M, et al. Cholestatic hepatitis due to an amoxicillin/clavulanic acid preparation. J Hepatol 1989;9:260-264
29. Berman S, et al. Effectiveness of continuous vs. intermittent amoxicillin to prevent episodes of otitis media. Pediatr Infect Dis J 1992;11(2):63-67.
30. Brook I, et al. Prophylaxis with amoxicillin or sulfisoxazole for otitis media: effect on the recovery of penicillin-resistant bacteria from children. Clin Infect Dis 1996;22:143-145
31. Casselbrant ML, et al. Efficacy of antimicrobial prophylaxis and of tympanostomy tube insertion for prevention of recurrent otitis media: results of a randomized clinical trial. Pediatr Infect Dis J 1992;11(4):278-286.
32. De Diego JI, et al. Comparison of amoxicillin and azithromycin in the prevention of recurrent otitis media. Int J Ped Otorhinolaryng 2001;58:47-51.
33. Marchisio P. Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children. Antimicrob Agents Chemo Dec 1996;40(12):2732-2736.
34. Mandel EM. Efficacy of antimicrobial prophylaxis for recurrent middle ear effusion. Pediatr Infect Dis J 1996;15(12):1074-82
35. Principi N, et al. Prophylaxis of recurrent acute otitis media and middle ear effusions. Am J Dis Childr Dec 1989;143:1414-1418.
36. Roark R, et al. Continuous twice daily or once daily amoxicillin prophylaxis compared with placebo for children with recurrent acute otitis media. Pediatr Infect Dis J 1997;16(4):376-81.
37. Teele DW, et al. Antimicrobial prophylaxis for infants at risk for recurrent acute otitis media. Vaccine 2001;19:S140-143.